Mariño SFP, Gradilla PR, González Fernández FA, Martínez AMV, Martínez SM, Bartol Puyal FDA, Palomar EV, Otal CI, Ciordia BC, Marsal JOC, Bakali Badesa S, García Ortego JA, Martínez AG, Gracia MÁM, Recasens V. Sickle cell disease associated with thalassemia; description of a rare mutation.
Clin Biochem 2021;
94:80-82. [PMID:
33901469 DOI:
10.1016/j.clinbiochem.2021.04.016]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2020] [Revised: 04/11/2021] [Accepted: 04/16/2021] [Indexed: 11/27/2022]
Abstract
Sickle cell disease (SCD) is a common hemoglobinopathy, secondary to alterations in the β globin chain, resulting in an abnormal hemoglobin variant named as hemoglobin S. These disorders show a wide phenotypical spectrum, and the prevalence of these disorders has significantly changed over the time because of multiple factors such as migration. We report a case of a 17-year-old black male, born in Gambia, diagnosed with sickle cell disease, who presented an associated mutation only described in a Japanese family (Oshima et al., 1996).
Collapse